Johnson & Johnson announced additional Week 12 results from the Phase 2b ANTHEM-UC study of icotrokinra, a first-in-class investigational targeted ...

In top-line results, the phase III trial demonstrated a “highly clinically meaningful reduction” in 24-hour systolic BP.

Organizations can instantly repurpose compromised endpoints with IGEL OS, supported by Omnissa Horizon cloud-enabled Desktop ...

Get ready to explore the thrilling rumors surrounding Wrath of the Lich King Classic! With discussions heating up around the ...

Microsoft has acknowledged a software defect in Microsoft Defender for Endpoint that has triggered misleading security alerts on Windows 11 version 25H2.The problem incorrectly flags Dell BIOS ...

Spruce Biosciences received FDA Breakthrough Therapy Designation for TA-ERT in treating San Filippo Syndrome Type B [MPS IIIB ...

Apple has used the tragic event where an estimated 8.5 million Windows PCs were knocked offline to promote the safety and ...

The FDA is expected to decide on treatments for achondroplasia, acute myeloid leukemia, familial chylomicronemia syndrome, immunoglobulin A nephropathy, and non-small cell lung cancer.

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION. The Summit theme "unlocking the $1 Trillion Wealth transfer in Dubai" PHILADELPHIA, PENNSYLVANIA / ACCESS ...

Skye Bioscience announces topline CBeyond phase 2a data from nimacimab monotherapy and combination clinical trial: San Diego Tuesday, October 7, 2025, 18:00 Hrs [IST] Skye Bioscie ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays ...

A multicenter trial from the Netherlands suggests that meticulous donor selection and anaerobic stool preparation may enhance ...